Free Trial

Citius Oncology (CTOR) Stock Chart & Stock Price History

$0.98 -0.01 (-0.51%)
(As of 01:30 PM ET)

Citius Oncology Stock Price Performance

5 Day
Performance
-7.08%
1 Month
Performance
-17.23%
3 Month
Performance
-48.96%
Receive CTOR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Citius Oncology and its competitors with MarketBeat's FREE daily newsletter.

CTOR Stock Chart for Thursday, November, 21, 2024

Citius Oncology Stock Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
11/20/2024$0.98$0.99
+0.62%
$1.03$0.9549,748 shs$2.33 million
11/19/2024$0.96$0.98
+2.28%
$1.05$0.9727,507 shs$2.32 million
11/18/2024$1.06$0.96
-9.25%
$1.07$0.9644,790 shs$2.27 million
11/15/2024$1.07$1.06
-0.84%
$1.13$1.0351,703 shs$2.50 million
11/14/2024$1.22$1.07
-12.38%
$1.19$1.0681,561 shs$2.52 million
11/13/2024$1.31$1.22
-6.87%
$1.36$1.1874,524 shs$2.88 million
11/12/2024$1.35$1.31
-2.96%
$1.41$1.25116,281 shs$3.09 million
11/11/2024$1.27$1.35
+6.30%
$1.43$1.18468,137 shs$3.18 million
11/08/2024$1.26$1.27
+0.77%
$1.39$1.2189,179 shs$3.00 million
11/07/2024$1.18$1.26
+6.81%
$1.31$1.1847,787 shs$2.97 million
11/06/2024$1.19$1.18
-1.02%
$1.32$1.13115,147 shs$2.79 million
11/05/2024$1.03$1.19
+15.74%
$1.20$1.02159,377 shs$2.81 million
11/04/2024$1.14$1.03
-9.65%
$1.12$1.0170,403 shs$2.43 million
11/01/2024$1.20$1.15
-4.17%
$1.21$1.1533,093 shs$2.71 million
10/31/2024$1.21$1.20
-0.83%
$1.22$1.1614,918 shs$2.83 million
10/30/2024$1.21$1.21
-0.36%
$1.27$1.1521,651 shs$2.85 million
10/29/2024$1.17$1.21
+3.79%
$1.27$1.1945,834 shs$2.87 million
10/28/2024$1.19$1.17
-1.82%
$1.21$1.1362,336 shs$2.76 million
10/25/2024$1.23$1.19
-3.25%
$1.25$1.1724,163 shs$2.81 million
10/24/2024$1.24$1.23
-0.81%
$1.27$1.1451,114 shs$2.90 million
10/23/2024$1.31$1.24
-5.34%
$1.39$1.20107,682 shs$2.90 million
10/22/2024$1.19$1.31
+10.08%
$1.40$1.21156,892 shs$3.07 million
10/21/2024$1.24$1.19
-4.03%
$1.32$1.13131,693 shs$2.81 million


This page (NASDAQ:CTOR) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners